Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Karagoz B et al. – Sunitinib, a multiple receptor tyrosine kinase inhibitor, is used in the treatment of renal cell carcinoma and gastrointestinal stromal tumors. The authors present a 57–year–old man with metastatic RCC who had transient subclinical hyperthyroidism and hypothyroidism during sunitinib therapy.

Today in Hematology/Oncology...keeping you current

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09

Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09

Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address